TY - JOUR
TI - Adverse Event (AE) Management With Pomalidomide (POM)+ Low-Dose Dexamethasone (LoDEX) in the STRATUS (TM) Trial: A Phase 3b Study Evaluating Safety and Efficacy in Patients (Pts) With Refractory or Relapsed and Refractory Multiple Myeloma (RRMM)
AU - Cavo, M
AU - Dimopoulos, MA
AU - Moreau, P
AU - Palumbo, A
AU - Corradini, P
AU - Weisel, K
AU - Ocio, E
AU - Doyen, C
AU - Anttila, P
AU - Raymakers, R
AU - others
JO - Clinical Lymphoma Myeloma and Leukemia
PY - 2015
VL - 15
TODO - null
SP - e264
PB - Elsevier
SN - null
TODO - null
TODO - null
TODO - null
ER -